This morning’s announcement may have surprised many investors following the Pharmaxis (ASX: PXS) story because where on earth does Parkinson’s fit into the equation alongside cancer, skin scarring and cystic fibrosis? Unpacking the Pharmaxis investment case reveals an agile company with more than one trick up their sleeves, keeping business buoyant whilst other biotechs list
Read More
Although some pandemic trends have lost momentum by returning to their pre-Covid status, one that shows no signs of slowing is digital payments, evidenced by revenue growth from Novatti Group (ASX: NOV) which has invested heavily in their ecosystem and is now eyeing positive cash flow. Operating a global ecosystem that facilitates digital payments, including
Read More
When they appointed a former Israeli Air Force Captain as their CEO 12 months ago, artificial intelligence company Crowd Media (ASX: CM8) knew they were going to see discipline instilled and the financial results of that appointment have begun bearing fruit through a $1 million upswing in FY22 earnings. For the year ended 30 June
Read More
Fintech company Douugh (ASX: DOU) touts itself as a responsible financial “super app” dedicated to financial wellbeing but they may ironically need to consider their own financial health after reporting a loss of $11.6 million, blaming wasted marketing spend and employee benefit expenses. While they managed to generate $600k in revenue from their super app,
Read More
Having serviced delivered more than 1.6 million patient appointments over the past year, allied health company Healthia (ASX: HLA) has such a large pipeline of acquisition targets that they have confirmed a new strategic vision of becoming the largest diversified allied healthcare provider in Australia and New Zealand. The ambitious goal has been set by
Read More
Australia’s largest publicly listed video games developer, PlaySide Studios (ASX: PLY), has delivered a record year today in another period of consecutive growth. PlaySide has hit records across the board; commercial revenue came in at $29.24 million, a significant increase of 169% from $10.88 million in FY21. Record EBITDA of $5.9 million, was up slightly
Read More